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Background: The preferred treatment of intertrochanteric fractures in aged patients is controversial. The purpose of
the present study was to evaluate the outcomes of the Asian proximal femur intramedullary nail antirotation system
(PFNA-II) for stabilization of such fractures.
Methods: The PFNA-II was used to treat intertrochanteric fractures in 163 elderly patients from March 2010 to March
2013. The patients comprised 69 men and 94 women with a mean age of 74.7 ± 13.0 years. All fractures were classified
by the Orthopaedic Trauma Association classification system; 53, 83, and 27 fractures were classified as 31A1,
31A2, and 31A3, respectively. We statistically evaluated the intraoperative blood loss, operation time, incision
length, X-ray exposure time, and postoperative outcomes. Patients were followed up for a mean of 15.2 months
(range, 10–24 months). Functional outcomes were assessed according to the Harris hip scoring system.
Results: Statistical analysis revealed an average operation time of 45.7 min (range, 35–110 min), average
intraoperative blood loss of 115.2 mL (range, 65–430 mL), X-ray exposure time of 2.7 ± 1.4 s (range, 2–6 s), and
total incision length of 6.5 ± 2.2 cm (range, 5.5–13.0 cm). Patients were followed up for a mean of 14.5 months
(range, 10–24 months). The neck shaft angle was 134° ±15° (range, 115°–150°), and the fracture healing time was
14.0 ± 2.5 weeks (range, 11–19 weeks). The Harris hip score was 85.6 ± 17.5 points (range, 65–100 points) and
included 41 excellent cases (25.15%), 92 good cases (56.44%), 26 moderate cases (15.95%), and 4 poor cases
(2.45%) for a positive outcome rate of 81.60%. There were no varus hip deformities, screw cutouts, or femoral
shaft fractures. Fourteen patients had thigh pain (9.82%), and five had inner thigh pain (3.07%); seven had more
severe pain that was improved by physical therapy.
Conclusion: PFNA-II has the advantages of a simple operation, few complications, and clinical efficacy for the
treatment of intertrochanteric fractures. However, evaluation of its long-term efficacy and risk of other complications
requires a large-sample, multicenter observational study.Introduction
The incidence of intertrochanteric fractures is increasing
with the aging of society. Treatment of intertrochanteric
fractures in elderly patients is a huge challenge for many
trauma surgeons, mainly because many such patients
have severe osteoporosis and medical disorders that in-
crease the risks associated with surgery and anesthesia.
Therefore, choosing the optimal fixation method and in-
strumentation is essential for a positive therapeutic effect.* Correspondence: Liuyang19642000@163.com
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unless otherwise stated.In 2003, the proximal femoral nail antirotation (PFNA)
system was put into clinical use by the Association
for Osteosynthesis/Association for the Study of Internal
Fixation (AO/ASIF). Although the use of the PFNA for
treatment of proximal femoral fractures has achieved
good clinical efficacy, a series of complications in Asian
patients has been reported in the literature. In 2009, the
AO/ASIF organization established the characteristics of
the PFNA for Asian patients (PFNA-II). Few published
reports have systematically assessed the role of the
PFNA-II in the stabilization of intertrochanteric frac-
tures. From March 2010 to March 2013, the PFNA-IIhis is an Open Access article distributed under the terms of the Creative
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Table 1 Preoperative patient data
Variables Value
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tures in 163 elderly patients.Patients 163
Female 94
Male 69
Mean age, years (SD) 74.7 ± 13.0
OTA classification
31A1 (%) 53 (32.5)
31A2 (%) 83 (50.9)









Hypertension and cardiovascular diseases 82
Sequelae of cerebral infarction 32
Diabetes mellitus 37
Chronic renal insufficiency 32Materials and methods
Materials
In total, 207 patients aged >65 years with peritrochan-
teric femoral fractures were treated with the PFNA-II at
the Fifth Hospital of Wuhan City from March 2010 to
March 2013 and enrolled in this study. After exclusion
of patients with pathological fractures, trauma, and open
injury, 163 patients were included in the statistical ana-
lysis. The patients comprised 69 men and 94 women
with a mean age of 74.7 years (range, 65–95 years). This
study was approved by the ethics committee of our
hospital, and informed consents were obtained from
patients or their authorized persons.
According to the Orthopaedic Trauma Association
(OTA) classification system, 53 (32.52%) fractures were
classified as 31A1, 83 (50.92%) as 31A2, and 27 (16.56%)
as 31A3. Accidental falls occurred in 117 cases and traf-
fic accident injuries in 46. All patients had closed frac-
tures (multiple injuries were not selected). In total, 122
patients had more than one type of disease: 82 had
hypertension, 32 had cerebral infarction, 37 had type II
diabetes, and 32 had renal insufficiency; 7 patients under-
went surgical operations on the contralateral femur.
According to the American Society of Anesthesiologists
(ASA) scoring system, 46, 85, and 32 patients had an ASA
status of I, II, and III, respectively (Table 1).Methods
Perioperative examination and treatment
After admission to the hospital, each patient’s limb was
elevated on a Blanc frame and abducted. If the patient was
expected to undergo surgery within 7 days, the limb bones
underwent only skin traction, not skeletal traction.
Elderly patients often have various medical disorders,
and perioperative examination and treatment are thus
very important. For patients aged >70 years, we routinely
performed ultrasound examinations of the heart, verte-
bral arteries, and lower extremity vasculature and assess
cardiac function, excluding patients with vertebral artery
and deep vein thrombosis. For patients with respiratory
infections, we administered preoperative antibiotics to
maintain the patient’s hemogram and C-reactive protein
level within acceptable limits. The blood glucose level of
patients with diabetes was monitored seven times daily,
excluding some patients with mild diabetes. Insulin
therapy was administered to most patients, and the daily
fasting and postprandial glucose levels did not exceed
10 mmol/L. A first-generation cephalosporin antibiotic
was administered to prevent infection 30 min before sur-
gery and again within 24 h; for selected patients (such asthose with diabetes), antibiotic treatment was extended
to 48 h.
Preoperative preparation
Before surgery, all patients underwent lateral femoral X-
rays, estimation of the size of the canal, and determin-
ation of the nail diameter and length. For patients with a
shorter height, we carefully considered whether or not
to use the PFNA-II. For taller patients, patients with
Evans type IV fractures and patients whose fracture line
extended below the lesser trochanter, a 200- or 240-mm
nail length was considered to increase the stability of the
fixation.
Surgical methods
All operations were completed by an experienced ortho-
pedic surgeon. The first three operations were not in-
cluded in the study analysis to eliminate the effect of the
learning curve.
The patient was placed in the supine position on an
extension table. The hip and knee of the healthy limb
were flexed and abducted to facilitate lateral C-arm
fluoroscopy. A single pad was placed under the hip to
raise the limb by 5 cm, and the limb was adducted about
10°. The fracture was reset under C-arm X-ray fluoros-
copy. An approximately 4- to 7-cm proximal and longi-
tudinal incision was made through the fascia and gluteus
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canal was then opened by evenly applied force to avoid
breakage of the greater trochanter. After insertion of a
reamed nail, fluoroscopy was performed to evaluate the
fracture situation. By the anteroposterior C-arm fluoros-
copy, the guide pin is located in 1/3 of the femoral neck
and located central of the femoral neck by lateral fluor-
oscopy. If the position of the guide pin was poor, then
the pin should be adjusted to the correct position, but
repeated adjustments should be avoided. For unstable
Evans type III or IV fractures, in order to prevent the
spiral area of the femoral head when the spiral blade was
being pounded, we can insert it into an antirotation
guide pin.
Postoperative rehabilitation
The first day after the isometric quadriceps and ankle
pump exercises had been performed, the first 2 days of
hip and knee flexion and extension exercises were initi-
ated and the patients’ X-rays were reviewed. The mean
time of part load of 31A1 fractures was 9.2 days (range,
5–14 days), that of 31A2 fractures was 21.7 days (range,
18–35 days), and that of 31A3 fractures was 41 days
(range, 35–72 days). The patient was allowed to bear full
weight after the disappearance of the fracture line on X-
rays.
Postoperative follow-up and treatment evaluation
The operative time was defined as the duration of time
from the start of closed reduction to completion of
wound suturing. The operative time, fluoroscopy time,
blood loss during surgery, and load time after the oper-
ation were evaluated by retrospective statistical analysis.
The average follow-up period was 14.5 ± 6.2 months
(range, 10–24 months). Clinical and radiographic exami-
nations were performed at 4 and 6 weeks and at 3, 6, 12,
and 18 months postoperatively. A Harris hip score of 90
to 100 was considered excellent, 80 to 89 was considered
good, 70 to 79 was considered moderate, and ≤69 was
considered poor.
Ethical considerations
All patients gave informed consent prior to their inclu-
sion in the study. All human studies were approved by
the Ethics Committee of the Second Affiliated Hospital
of Jianghan University and were performed in accord-
ance with ethical standards.
Results
In total, 163 patients underwent either closed reduction
(n =131) or limited open reduction (n =32). The average
time from injury to surgery was 3.7 days (range, 2–14
days). The mean operative time was 45.7 min (range,
35–110 min), intraoperative blood loss was 115.2 mL(range, 65–430 mL), number of intraoperative C-arm
fluoroscopy procedures was 2.7 ± 1.4 (range, 2–6), and
total incision length was 6.5 ± 2.2 cm (range, 5.5–
13.0 cm). The PFNA-II is available in three different
lengths: the standard length (240 mm) was used in 22
patients, a length of 200 mm was used in 92 patients,
and a very short length (170 mm) was used in 49
patients. The PFNA-II is also available in three different
diameters: 9 mm was used in 42 patients, 10 mm was
used in 93 patients, and 11 mm was used in 28 patients.
Because patients who sustained traffic accident injuries
were hospitalized for a longer period of time, statistical
evaluation of the hospital stay was not performed. All
patients were followed up for 14.5 ± 6.2 months (range,
10–24 months).
X-ray evaluation showed a neck-shaft angle of 134° ±15°
(range, 115°–150°). Postoperatively, patients with type
31A1 fractures had an average loading time of 11.2 days
(range, 7–16 days), those with type 31A2 fractures had an
average loading time of 21.7 days (range, 18–35 days), and
those with 31A3 fractures had an average loading time of
41.6 days (range, 35–72 days). The fracture healing time
averaged 14.0 ± 2.5 weeks (range, 11–19 weeks). No pa-
tients exhibited postoperative nonunion, varus, or nail
fracture. One patient developed reamer cutout into the
acetabulum, and three developed reamer exit. Sixteen pa-
tients developed outer thigh pain (9.82%), and five devel-
oped inner thigh pain (3.07%); after the administration of
nonsteroidal anti-inflammatory drugs (NSAIDs) and the
performance of physical therapy, seven patients with
severe pain experienced improvement. After the last
follow-up, the mean Harris hip score was 85.6 ± 17.5
(range, 65–100); the score was excellent in 41 patients
(25.15%), good in 92 (56.44%), moderate in 26 (15.95%),
and poor in 4 (2.45%) for a positive outcome rate of
81.90% (Tables 2 and 3).
Discussion
Intertrochanteric fractures often occur in older patients.
According to some orthopedic surgeons, stable intertro-
chanteric fractures (Evans type I) can be effectively
treated with conservative therapy and that surgical treat-
ment should be reserved for unstable intertrochanteric
fractures [1]. However, we believe that as long as the pa-
tient is expected to tolerate surgery according to their
preoperative examination results, surgery should be per-
formed even for stable undisplaced intertrochanteric
fractures as soon as possible after the patient stands or
sits up to avoid pressure sores and hypostatic pneumo-
nia while reducing the risk of nonunion. Studies have
shown that surgical treatment of intertrochanteric frac-
tures is associated with a significantly lower mortality
rate and higher quality of life than achieved with conser-
vative treatment [2].




Limited open reduction 32
Average time from injury to surgery (day) 3.7 (2–14)
Operation time (min) 45.7 (35–110)
Intraoperative blood loss (mL) 115.2 (65–430)
Intraoperative fluoroscopy times 2.7 (2–6)
Incision total length (cm) 6.5 (5.5–13)
Neck-shaft angle (°) 134 (115–150)
Fracture healing time (weeks) 14 (11–19)








Start loading time after surgery
31A1 11.2 (7 ~ 16 days)
31A2 21.7 (18 ~ 35 days)
31A3 41.6 (35 ~ 72 days)
Harris hip score 85.6 (65 to 100 points)
Excellent 41 cases (25.15%)
Good 92 cases (56.44%)
Medium 26 cases (15.95%)
Poor 4 cases (2.45%)
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plate fixation system and is considered to be the gold
standard treatment for intertrochanteric fractures. It
has been widely used for this purpose, and years of clin-
ical experience have demonstrated good clinical efficacy
in stabilizing intertrochanteric fractures [3,4]. However,
the dynamic hip screw does have some drawbacks,
especially after application to unstable intertrochanteric
fractures of the medial cortex because varus deformity
and plate fracture can easily occur in such cases [5,6].Table 3 Postoperative complications
Complications Cases
Cutout of the blade 3
Femoral head penetration of the blade 1
Thigh pain (outside) 16
Thigh pain (inside) 5In elderly patients with osteoporosis, the hip screw-
holding force is weaker than that in intramedullary
fixation, which is more prone to rotation, hip screw
cutting, and other complications [7,8]. Biomechanical
studies have shown that because the mechanical axis of
the intramedullary system is close to the center of the
body, its mechanical properties are better than those of
extramedullary fixation systems [9].
In 1998, the AO/ASIF organizational design and began
applying PFN treatment to intertrochanteric fractures.
Although the PFN overcomes many of the disadvantages
of the conventional intramedullary nail, there have been
many reports on the presence of the following complica-
tions of PFN in recent years: proximal screw cutting,
intraoperative distal locking screw insertion difficulties,
remote locking screw stress concentration caused by
vegetation breaking into the matter, the Z effect, ilioti-
bial tract irritation caused by anterior thigh pain, and
others [10-13].
Because the PFN has some defects, the AO/ASIF im-
proved the design of the PFN and introduced the PFNA
system in 2003. The main change in the PFNA involves
the end of the helical screw blade, which gradually in-
creases the diameter to allow for compression of the
bone around the femoral head, thereby stabilizing the
femur and facilitating antirotation and compression
[14,15]. Comparison of helical blades and ordinary lag
screws for fixation of the femoral head by biomechanical
methods in neck mechanic experiments has shown that
the stability of reamers is obviously better than that of
ordinary lag screws. The only drawback of the helical
blade is that it cannot withstand fracture pressure as can
ordinary lag screws; thus, surgeons should emphasize
good fracture reduction [16].
Although the PFNA has a substantial number of
advantages, many papers have reported complications
during its clinical use, especially in Asian patients. First,
the anatomical features of the PFNA do not match the
femoral geometry of Asian patients. The standard length
of a PFNA nail is about 200 mm, and the shortest is
170 mm. The stature of Asian patients is shorter than
that of European patients, and the anterior arch of the
physiological femoral curvature is relatively large; thus,
the tops of the main staples of the PFNA easily tip over
the anterior arch of the femoral curvature, resulting in
femoral fracture [17]. If a full presurgical assessment is
not performed to ensure that the diameter of the PFNA
nail matches the patient’s anatomy, the risk of hip frac-
ture during insertion may increase [18]. Second, the
proximal nail of the PFNA may be longer in patients
with a short stature so that walking induces friction be-
tween the nail and soft tissue of the thigh, causing pain
[19]. Finally, the outer side wall of the proximal PFNA is
circular, which will easily produce pressure on the lateral
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inserted, resulting in bone damage and reset loss [20].
Because of the abovementioned shortcomings in the
previous PFNA, The AO/ASIF improved the design and
launched the PFNA-II. The PFNA-II exhibits some im-
provements in the design. First, the outer angle of the
PFNA-II staples has been decreased from 6° to 5°, from
the needle to the apex of the greater trochanter, to en-
sure that the canal is located in the middle of the distal
nail and reducing the risk of the distal nail impacting the
femur. Second, the distance of the proximal of the PFNA
nail with the spiral blade and the tail cap of the spiral
blade is longer, the proximal nail of the PFNA-II has
been shortened to 45 mm, and the length of the helical
screw end cap has been reduced to 2.5 mm. This re-
duces friction between the nail and soft tissue and de-
creases activity-induced hip pain, which arises from the
friction of the nail with soft tissue. Third, the proximal
end of the outer wall of the PFNA-II improved the nail
from a round to a graphic design, thereby reducing
stress caused by the nail impacting the medial femoral
cortex and reducing the probability of fracture reduction
loss when the PFNA nail is inserted into the femoral
canal [21].
Although the PFNA-II has more advantages than the
former design and has been significantly improved, some
academic studies have shown that the femoral anterior
arch of the PFNA-II does not match the anatomy ofFigure 1 X-ray shows the tip of the PFNA-II against the lateral wall in
(a) Anteroposterior view. (b) Axial view.Asian patients. Even in the short-nail models of the
PFNA-II (170 mm), only about 19.0% of the distal tip of
the nail located in the central of needle canal, 74.7% lo-
cated in the former, and 6.3% in the rear of the needle
canal, not to mention the long nail. Contact irritation
was present between the inappropriate nail tip position
and the femoral cortex, which tended to increase patient
discomfort and pain. The treatise’s conclusion is that
both the long and short nails (nail length of ≤24 cm) re-
quire a curved design, which would be more suitable for
the femoral anterior arch shape in Asian patients [22].
In conclusion, the PFNA-II has many advantages.
First, the operation is simple and the operation time is
short. In our clinic, the mean operative time using the
PFNA-II was 42.5 min (range, 35–75 min), and major
surgical procedures were completed in 30 min. Second,
radiation exposure is low; the C-arm fluoroscopy of the
PFNA-II was 2.5 times (2–4 times) in this clinical group.
The main C-arm fluoroscopy focuses on whether the
correct position be placed before inserting the guide pin
and whether the location of the guide pin is correct after
nail insertion. Third, the incidence of bleeding is low.
Compared with the nail–plate system, the PFNA-II only
exposes the tip of the greater trochanter, and most pa-
tients with osteoporosis do not require proximal ream-
ing; therefore, the incision is small and less bleeding
occurs during surgery. The volume of bleeding in our
surgical group was only 67.5 mL (range, 42–150 mL).elderly patients with a larger natural anterior bow of the femur.
Figure 2 In patients with a short stature, even after the use of a 170-mm PFNA nail, some portion of the long tail was still exposed
outside of the greater trochanter, with hip joint activity easily leading to pain. (a, b) Postoperative three-dimensional imaging.
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cell transfusion, no patients required an intraoperative
or postoperative blood transfusion.
The authors’ experience with the PFNA-II has shown
that careful preoperative assessment is very important.
Anteroposterior and lateral X-rays should be obtained
preoperatively to estimate the size of the canal. ForFigure 3 Patients with severe osteoporosis may develop reamer cutti
cutting occurred in the presence of severe osteoporosis. (b) The entrance popatients with a short stature or a large physiological
femoral curve, the clinician should carefully consider
whether or not to apply the PFNA-II. Because the short,
narrow canal of most patients should undergo repeated
reaming during surgery, the operative time will increase
and blood loss will be significantly higher. In fact, most
bleeding arose from the canal during the application ofng or piercing of the femoral head or back nails. (a) Reamer
ints of the PFNA nail needle are lateral deviation and the reamer exit.
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of bleeding during repeated reaming was much higher
than that in patients who did not undergo reaming. For
patients with greater physiological femoral bending, the
edge of the femur easily came into contact with the front
or rear femoral cortex, causing severe pain (Figure 1).
In addition, compared with short-statured patients, the
distance between the proximal aspect of the nail and the
spiral blade still appeared to be relatively long. When
the patient moved, the end of the nail exposed outside
of the rotor readily came into contact with the iliotibial
band, causing pain (Figure 2).
In this experiment, outer thigh pain was present in 16
patients (9.82%), and inner thigh pain (3.07%) was
present in five patients (3.07%). Seven patients with
severe pain experienced improvement after treatment
with NSAIDs and physical therapy, and the remaining
patients underwent no special treatment.
Additionally, patients with severe osteoporosis may
develop reamer cutting or piercing of the femoral head
or back nails. One patient in this study developed
reamer cutting and three developed piercing of the back
nail; this prolonged the hospitalization time to allow for
removal of the internal fixation device and allow for
fracture healing (Figure 3).
We also believe that the most critical step of the surgi-
cal procedure is choosing the correct entry point before
insertion of the PFNA-II needle. In general, the entry
point is located at the top of the greater trochanter or
slightly (about 3 mm) medially. An incorrect needle
entry point will make nail insertion difficult. A violent
insertion may lead to cortical rupture of the greater
trochanter. Repeated reaming will increase the amount of
bleeding and prolong the operative time. Determination of
the position of the guide pin in the femoral neck is equally
important. The best location of the needle is the lower
one-third of the femoral neck, and it should be placed
under anteroposterior fluoroscopy; when located in the
center of the femoral neck, it should be placed under lat-
eral fluoroscopy. If the position of the spiral blade in the
femoral neck is too high, the risk of withdrawal or cutting
of the spiral blade into the femoral head increases because
of severe osteoporosis. When the spiral blade position is
too low, it may damage the medial cortex of the intertro-
chanteric fossa and increase the risk of hip varus. After
determining the position of the guide pin, it is crucial to
measure its depth to determine the length of the spiral
blade. Measurement of the depth of the needle guide
should ensure that the sleeve is installed against the lateral
femoral cortical bone; otherwise, the measurement result
will be too long. A long spiral blade may increase the risk
of cutting into the femoral head or significant pain caused
by soft tissue friction with the end of the excessively long
helical blade.Conclusions
This study shows that use of the PFNA-II to treat inter-
trochanteric fractures in elderly patients has the follow-
ing advantages: a simple operation, few complications,
and good clinical efficacy. The time of clinical treatment
of PFNA-II was relatively short, and the clinical samples
observed in clinical treatment were relatively small; the
long-term complications remain unclear. Therefore, large-
sample, multicenter studies are required.
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